These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34205554)

  • 1. National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation.
    Årdal C; Lacotte Y; Edwards S; Ploy MC; On Behalf Of The European Union Joint Action On Antimicrobial Resistance And Healthcare-Associated Infections Eu-Jamrai
    Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34205554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally.
    Vogler S; Habimana K; Haasis MA; Fischer S
    Appl Health Econ Health Policy; 2024 Jun; ():. PubMed ID: 38837100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study.
    Dutescu IA; Hillier SA
    Infect Drug Resist; 2021; 14():415-434. PubMed ID: 33574682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe.
    Årdal C; Lacotte Y; Ploy MC
    Clin Infect Dis; 2020 Nov; 71(8):1994-1999. PubMed ID: 32060511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New business models for antibiotic innovation.
    So AD; Shah TA
    Ups J Med Sci; 2014 May; 119(2):176-80. PubMed ID: 24646116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repairing the broken market for antibiotic innovation.
    Outterson K; Powers JH; Daniel GW; McClellan MB
    Health Aff (Millwood); 2015 Feb; 34(2):277-85. PubMed ID: 25646108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.
    Simpkin VL; Renwick MJ; Kelly R; Mossialos E
    J Antibiot (Tokyo); 2017 Dec; 70(12):1087-1096. PubMed ID: 29089600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking Sustainable Use Policies to Novel Economic Incentives to Stimulate Antibiotic Research and Development.
    Theuretzbacher U; Årdal C; Harbarth S
    Infect Dis Rep; 2017 Mar; 9(1):6836. PubMed ID: 28458797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Obstacles to Implementing Economic Mechanisms to Stimulate Antibiotic Research and Development: A Multi-Actor and System-Level Analysis.
    Baraldi E; Ciabuschi F; Leach R; Morel CM; Waluszewski A
    Am J Law Med; 2016 May; 42(2-3):451-486. PubMed ID: 29086643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In tepid defense of population health: physicians and antibiotic resistance.
    Saver RS
    Am J Law Med; 2008; 34(4):431-91. PubMed ID: 19216245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing an EU pull incentive for antimicrobial innovation and access: blueprint for action.
    Anderson M; Towse A; Outterson K; Mossialos E
    Lancet Microbe; 2024 Jun; ():. PubMed ID: 38885690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving equitable access for effective antibacterial: an ecosystem approach.
    Cohn J; Balasegaram M; Srinivasan H; Menghaney L; Mpundu M; Waning B; Alimi Y
    Clin Microbiol Infect; 2024 Jun; ():. PubMed ID: 38909688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paving the Way for the Implementation of a Decision Support System for Antibiotic Prescribing in Primary Care in West Africa: Preimplementation and Co-Design Workshop With Physicians.
    Peiffer-Smadja N; Poda A; Ouedraogo AS; Guiard-Schmid JB; Delory T; Le Bel J; Bouvet E; Lariven S; Jeanmougin P; Ahmad R; Lescure FX
    J Med Internet Res; 2020 Jul; 22(7):e17940. PubMed ID: 32442155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic innovation for future public health needs.
    Theuretzbacher U
    Clin Microbiol Infect; 2017 Oct; 23(10):713-717. PubMed ID: 28652114
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.